Mesoblast (MESO) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mesoblast Limited has disclosed a change in the interests of Director Dr. Eric Rose, reporting an acquisition of 19,734 American Depositary Shares (ADSs) on-market, valued at US$151,207.83. The transaction has increased Dr. Rose’s indirect holdings to 41,162 ADSs, excluding the potential issue of additional ordinary shares pending shareholder approval at the upcoming Annual General Meeting.
For further insights into MESO stock, check out TipRanks’ Stock Analysis page.